건선 환자 101명의 6개월간의 한의학적 치료효과에 대한 후향적 연구
Retrospectie Study about the Effectieness of orean Medical Treatment on 101 Psoriasis Patients for 6 months
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objectives : The purpose of this study is to report the effectiveness of Korean Medicine Treatment on 101 psoriasis patients for 6 months. Methods : Psoriasis Area and Severity Index(PASI) is used for measuring the degree of psoriasis with photos of total 101 psoriasis patients who have visited Korean medical clinic from October 11, 2013 to August 31, 2017. And we analyzed the PASI score according to gender, age, period of treatment, being used steroid or not. Results : 1. The ratio of male to female was 44.55 : 55.45. The mean age of patients was 34.65 years old(All patients were constituted with 9.9% of 10~19 year-old group, 31.7% of 20~29 year-old group, 26.7% of 30~39 year-old group, 12.9% of 40~49 year-old group, 15.8% of 50~59 year-old group and 3.0% of 60~69 year-old group). 2. PASI score was significantly higher in men than in women before treatment, but there was no significant difference of PASI score improvement after 2, 4 and 6 months treatment in both men and women. 3. PASI score improvement according to age after 2, 4 and 6 months treatment was no significant difference. 5. In initial visit, the steroid group patients were 61 and non-steroid group patients were 40. PASI score in initial visit between steroid group and non-steroid group was no significant difference. And PASI score after 2, 4 and 6 months treatment was no significant difference. Conclusions : PASI score was significantly decreased after 2, 4 and 6 months treatment compared with before treatment. PASI score improvement was significantly increased in proportion to the period of treatment.
Abstract
Objectives : The purpose of this study is to report the effectiveness of Korean Medicine Treatment on 101 psoriasis patients for 6 months. Methods : Psoriasis Area and Severity Index(PASI) is used for measuring the degree of psoriasis with photos of total 101 psoriasis patients who have visited Korean medical clinic from October 11, 2013 to August 31, 2017. And we analyzed the PASI score according to gender, age, period of treatment, being used steroid or not. Results : 1. The ratio of male to female was 44.55 : 55.45. The mean age of patients was 34.65 years old(All patients were constituted with 9.9% of 10~19 year-old group, 31.7% of 20~29 year-old group, 26.7% of 30~39 year-old group, 12.9% of 40~49 year-old group, 15.8% of 50~59 year-old group and 3.0% of 60~69 year-old group). 2. PASI score was significantly higher in men than in women before treatment, but there was no significant difference of PASI score improvement after 2, 4 and 6 months treatment in both men and women. 3. PASI score improvement according to age after 2, 4 and 6 months treatment was no significant difference. 5. In initial visit, the steroid group patients were 61 and non-steroid group patients were 40. PASI score in initial visit between steroid group and non-steroid group was no significant difference. And PASI score after 2, 4 and 6 months treatment was no significant difference. Conclusions : PASI score was significantly decreased after 2, 4 and 6 months treatment compared with before treatment. PASI score improvement was significantly increased in proportion to the period of treatment.
참고문헌 (21)
- Textbook Compilation Committee of Korean dermatological association, "Dermatology", pp.299~314 (2014), Yeomoongak
- Clarke P, "Psoriasis", Aust Fam Physician, 40(7), pp.468~473 (2011)
- Shanu KK, "The risk of depression, anxiety, and suicidality in patients with psoriasis", Arch Dermatol, 146(8), pp.891~895 (2010)
- Nancy W, "Psoriasis", Am Fam Physician, 87(9), pp.626~633 (2013)
- Kim NK, "The oriental and occidental bibliographic study of Psoriasis", J Korean Med Ophthalmol Otolaryngol Dermatol, 12(1), pp.154~178 (1999)
- Youn SW, "The Assessment of Psoriasis Severity: PASI, BSA, DLQI", Journal of the Korean Society for Psoriasis, 10(1), pp.11~14 (2013)
- Rapp SR, "Psoriasis causes as much disability as other major medical diseases", J Am Acad Dermatol, 41, pp.401~407 (1999)
- Wahl A, "The impact of psoriasis on psychosocial life domains;A review", Scand J Caring Sci, 11, pp.243~249 (1997)
- Kurd SK, "The risk of depression, anxiety, and suicidality in patients with psoriasis : a population-based cohort study", Arch Dermatol, 146, pp.89~95 (2010)
- Choi JH, "Pruritus in Psoriasis", The Korean Society for Skin Barrier Research, 11(2) (2009)
- Gupta MA, "Pruritus in psoriasis. A prospective study of some psychiatric and dermatologic correlates", Arch Dermatol, 124, pp.1052~1057 (1988)
- Yeilding N, "Development of the IL-12", 23 antagonist ustekinumab in psoriasis: past, present, and future perspectives, 2011, pp.1222, 30~39
- 김준영, "건선에 사용되는 보완대체의학에 관한 조사", 대한피부과학회지, 48(6), pp.494~502 (2010), 대한피부과학회
- 홍석훈, "건선의 한의학적 치료에 관한 논문 경향 분석 - 국내 논문을 중심으로", 한방안이비인후피부과학회지, 26(4), pp.26~42 (2013), 대한한방안이비인후피부과학회
- Na SJ, "Clinical observation of the patients registered or the past 30 years (1982-2012) at Seoul National University Hospital Psoriasis Clinic", J Dermatol, 40(9), pp.731~735 (2013)
- Carlin CS, "A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis", J Am Acad Dermatol, 50(6), pp.859~866 (2004)
- 김상엽, "중등증 내지 중증 판상건선에서 Methotrexate와Cyclosporine A의 효능 및 부작용에 대한 비교", 대한피부과학회지, 52(9), pp.615~621 (2014), 대한피부과학회
- 임지홍, "한국인 건선환자 30명을 대상으로 5년동안 Ustekinumab과 Topical Agent 병용치료의 효과에 대한 후향적 연구", 대한피부과학회지, 55(3), pp.171~177 (2017), 대한피부과학회
- 양지은, "乾癬으로 3개월 이상 한약을 복용한 환자 82명의 간수치 변화", 대한한의학회지, 33(3), pp.95~104 (2012), 대한한의학회
- 이병철, "한약으로 치료 받은 건선 환자 107명의 안전성 및 유효성에 대한 고찰", 대한한의학회지, 37(1), pp.34~40 (2016), 대한한의학회
- Roh HJ, "Recent Advances in Topical Therapy of Psoriasis", Journal of the Korean Society for Psoriasis, 6(1), pp.1~6 (2009)